China NT Pharma Group Co., Ltd. ( (HK:1011) ) has shared an announcement.
China NT Pharma Group Co., Ltd. has announced its Annual General Meeting (AGM) scheduled for June 30, 2025, in Hong Kong. Key agenda items include the adoption of financial statements, re-election of directors, and re-appointment of auditors. The company also seeks shareholder approval to authorize the board to issue additional shares, reflecting its strategic focus on growth and capital management. This move could potentially impact the company’s market positioning and shareholder value.
More about China NT Pharma Group Co., Ltd.
China NT Pharma Group Co., Ltd. operates in the pharmaceutical industry, focusing on the development, manufacturing, and distribution of pharmaceutical products. The company is known for its commitment to providing quality healthcare solutions and has a significant market presence in Hong Kong.
YTD Price Performance: 114.81%
Average Trading Volume: 625,592
Technical Sentiment Signal: Sell
Current Market Cap: HK$391.1M
For detailed information about 1011 stock, go to TipRanks’ Stock Analysis page.